Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -77,098 | -183,793 | -133,357 | -66,092 | -23,348 |
| Depreciation Amortization | 591 | -1,821 | -2,279 | -2,422 | N/A |
| Accounts payable and accrued liabilities | 1,780 | 3,337 | 6,103 | 2,206 | 258 |
| Other Working Capital | 5,448 | 9,437 | 13,724 | 5,628 | -2,461 |
| Other Operating Activity | 26,648 | 41,280 | 27,224 | 1,662 | -3,868 |
| Operating Cash Flow | $-42,631 | $-131,560 | $-88,585 | $-59,018 | $-29,419 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | -268,356 | -262,340 | -235,746 | -162,458 |
| Sale Of Investment | 42,000 | 116,750 | 75,750 | 33,750 | N/A |
| Investing Cash Flow | $42,000 | $-151,606 | $-186,590 | $-201,996 | $-162,458 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 42,000 | 42,000 | 42,000 | N/A |
| Debt Repayment | N/A | -22,000 | -22,000 | -22,000 | N/A |
| Common Stock Issued | 1,476 | 263,662 | 1,848 | 1,099 | 423 |
| Other Financing Activity | 3,833 | -16,393 | -447 | -447 | 579 |
| Financing Cash Flow | $5,309 | $267,269 | $21,401 | $20,652 | $1,002 |
| Exchange Rate Effect | 3 | -7 | -8 | 13 | -12 |
| Beginning Cash Position | 257,837 | 273,741 | 273,741 | 273,741 | 273,741 |
| End Cash Position | 262,518 | 257,837 | 19,959 | 33,392 | 82,854 |
| Net Cash Flow | $4,681 | $-15,904 | $-253,782 | $-240,349 | $-190,887 |
| Free Cash Flow | |||||
| Operating Cash Flow | -42,631 | -131,560 | -88,585 | -59,018 | -29,419 |
| Free Cash Flow | -42,631 | -131,560 | -88,585 | -59,018 | -29,419 |